Classification First: The EDE Classification Letter and I-IV Risk Classes

1. Key takeaways

Classification is the first gate of the premarket pathway in the United Arab Emirates. The Classification of a Medical Product service published on the EDE website carries an official turnaround of 10 working days and produces a classification letter that confirms the regulatory class of the product and whether a marketing authorization is required. Our judgment is that Chinese manufacturers should not substitute self-assessment for the classification letter, because the classification outcome directly determines whether the product then enters the 45-working-day marketing authorization review, whether safety and effectiveness data must be submitted for Class III and Class IV devices, and how deeply reference-country evidence under Article 6(1)(c) must be organised. Acting on classification first absorbs rework costs up front, instead of leaving the manufacturer to supplement documents passively at the filing stage.

• The classification service runs on an official timeline of 10 working days and issues a letter stating the regulatory class and whether a marketing authorization is needed.
• The classification outcome drives everything downstream: the 45-working-day authorization review, the safety and effectiveness data required for Class III and IV devices, and the depth of Article 6(1)(c) reference-country evidence.
• Misjudgements concentrate on borderline products rather than typical ones: combination products, software-bearing devices, and IVD-plus-delivery-device pairings are the ones most easily under-classed as single-purpose items.
• IVDs follow a separate A, B, C, D scheme whose call depends on the purpose of the test, its subject and the consequence of an erroneous result, and cannot borrow the device Class I–IV logic.

2. Legal basis

The regulatory and service-level basis for classification in the United Arab Emirates is set out in the table below, drawn from Federal Decree-Law No. 38/2024 and the EDE service page for classification.

3. Expert insights

Insight 1: The 10-working-day figure is a review timeline, not a delivery timeline. The clock starts only once the submission is complete and formally accepted, and it excludes the back-and-forth caused by a missing product catalogue, missing instructions for use or missing certificates. We therefore manage the classification stage in three segments — acceptance, document supplementation and review — rather than counting 10 working days backwards from the intended launch date. For the overall period from zero preparation to formal market entry, industry practice runs at 6–18 months (practical estimate), and that wider window is what commercial planning should be built on.

Insight 2: Misjudgements concentrate on borderline products rather than typical ones. Combination products, devices incorporating software, and the pairing of an IVD with an administration device are the categories most easily under-classed when each element is assessed as a single-purpose item in isolation. The real cost of a misjudgement does not sit in the classification fee itself; it sits downstream. Once a product is placed in Class III or Class IV, the EDE marketing authorization service page requires additional safety and effectiveness data, and a technical file organised around a lower-risk assumption has to be substantially rebuilt. IVDs are judged under a separate A, B, C, D scheme: the outcome depends on the purpose of the test, the subject being tested and the consequence of an erroneous result, and the Class I–IV device logic cannot simply be transposed onto it.

Insight 3: During the current gap period, classification conclusions must leave a written trace. Article 6(1)(h) leaves other conditions for obtaining an authorization to the Executive Regulations, and the Executive Regulations under the Decree-Law have not yet all been issued. Our approach is to obtain a classification letter for every borderline product without exception, so that the conclusion exists on paper. Where the view of EDE may diverge from prevailing industry practice, we seek written confirmation rather than relying on what peers happen to be doing.

4. Practical recommendations

• Submit the classification application at the project initiation stage, lock the class with the classification letter, and only then start organising the technical file and reference-country evidence.
• Assemble the dossier exactly as listed on the EDE classification service page: the product catalogue, product images, a certificate of product status (CPP/CFS/ISO/CE) issued by the competent authority of the country of origin, instructions for use in English or Arabic, and artwork for the inner and outer packaging labels.
• List the main unit, its accessories and its software modules within the registration unit item by item, so that the review does not separately classify components that were never declared.
• Establish triggers for classification reassessment: re-evaluate the classification whenever the intended purpose, the target population, software algorithms or key materials change.
• Budget the classification service fee at AED 500 (practical estimate) and keep it separate from the AED 5,000 medical device registration fee, so that the two fee bases are never mixed.

5. Verification checklist

• □ The EDE classification letter has been obtained and states the regulatory class and the conclusion on whether a marketing authorization is required.
• □ The models in the product catalogue correspond one-to-one with the models to be registered, with no accessories or software modules omitted.
• □ The certificate of product status (CPP/CFS/ISO/CE) issued by the competent authority of the country of origin is within its validity period.
• □ The instructions for use are available in English or Arabic, and the artwork for inner and outer packaging labels has been prepared in parallel.
• □ The link between the classification conclusion and the safety and effectiveness data requirements for Class III and IV devices has been confirmed.
• □ The product name and the intended purpose stated in the classification letter are identical to those in the subsequent filing documents.

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team manages MOHAP registration applications, prepares reference-approval dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com